1. Find new tests in blood, urine, semen, or biopsy (or surgery) samples that can tell if a patient has prostate cancer.
2. Find tests that can identify aggressive cancers.
To discover these tests, blood, urine, semen and clinical information from close to 4000 men are required. We plan to enroll patients over a period of 5 years in Calgary and Edmonton.
In Calgary, recruitment will occur at the Prostate Cancer Centre and Tom Baker Cancer Centre. In addition, participants may join the study by contacting the Calgary study coordinator at 403-943-8942.
In Edmonton, recruitment will occur at the Northern Alberta Urology Centre and Cross Cancer Institute. In addition, participants may join the study by contacting the Edmonton study coordinator at 780-407-5914.
Ask your doctor if you are eligible to participate in the study!
Download the Alberta Prostate Registry and Biorepository Information Brochure.
Download the Alberta Prostate Cancer Registry and Biorepository Information Brochure.
Cancer Control Alberta reduces the impact of cancer on all Albertans and provides expert care and support for patients from their first symptom to survivorship. Supporting world-class research are two specialized teams that operate within the Clinical Trials Units at the Cross Cancer Institute and the Tom Baker Cancer Centre. Each team provides well-trained staff and comprehensive services to researchers who are conducting clinical trials. In addition to the cancer centres, The Prostate Cancer Centre in Calgary and the Northern Alberta Urology Centre in Edmonton are testing advances in diagnosis and treatment to improve quality of life and work towards a cure for prostate cancer.
Congratulations to Drs. John Lewis, Eric Hyndman, Morley Hollenberg and Harvey Quon for being awarded each with a JAHIP grant (Johnson & Johnson Alberta Health Innovation Partnership) to better diagnose prostate cancer using different platforms and to determine mutations in patients with high-risk PCa.
This is a great opportunity to start long-lasting partnerships with J&J and the University Hospital Foundation and to develop new and better tests for PCa.
The original plan was to fund 2 applications, however, due to the high quality of the proposals, the committee decided to grant 2 more.